2:00 pm, First Presbyterian Church, New Bern
Gianpietro Dotti, MD, is a world leader in the field of cancer cellular immunology, which involves extracting disease-fighting immune cells from the patient’s blood and genetically engineering them to recognize the patient’s cancer.
Dr. Dotti’s research achievements include contributing to the development of an innovative “safety switch” that is used in partnership with immunotherapy to turn of the therapy when necessary. He also has facilitated the development and implementation of more than 10 cell therapy trials using gene modified T-cells, which are the disease-fighting immune cells.
Gianpietro Dotti is Professor of Microbiology and Immunology at UNC School of Medicine, UNC Lineberger Comprehensive Cancer Center.
Rothermel events are free and open to the public, and include the opportunity to engage in with the speaker in a question and answer session.